Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Reducing the need for blood transfusions is desirable
for several reasons. Since 2000 in the United Kingdom it has been
mandatory to remove all white cells from donated blood to reduce the
small but theoretical risk of prion disease (variant Creutzfeldt-Jakob disease). This has trebled the cost of providing donated blood. Transmission of hepatitis B, hepatitis C, and HIV by transfusion occurs
in 1 in 300 000 cases, despite screening programmes.1 However, non-fatal but serious transfusion errors occur in 1 in 16 000 transfusions.1
Critically ill patients are now known to do just as well with a lower
haemoglobin concentration than previously thought, thus reducing the
need for top-up transfusions.2 There is also some evidence
that homologous blood transfusions increase the rates of recurrence of
some cancers (tumours of the bowel and oesophagus, in particular) and
can increase the incidence of wound infections.3 It is
unclear why these phenomena occur.
A number of mechanical methods have been developed to help reduce the
need for postoperative blood transfusions. In the United States
erythropoetin injections or autologous blood donations (or both), given
preoperatively, are commonly used. Both require the exact date of
surgery to be known Perioperative dilution and intraoperative blood salvage techniques
(such as those described in this paper) are gaining credence, particularly for patients undergoing cardiac and orthopaedic surgery. But neither of these processes is suitable for patients with infection or malignant disease.
After surgery, devices are available to collect blood from wound
drains, which can then be retransfused back into the patient. Such
techniques reduce the formation of haematomas, but few studies of their
efficacy are available, and the techniques are not in general
use.4
BMJ
but neither process is free from human error in
labelling, storing, and administration.
References
| 1. | Williamson L, Cohen H, Love E, Jones H, Todd A, Soldan K, et al. The Serious Hazards of Transfusion (SHOT) Initiative. Vox Sang 2000; 78(suppl 2): 291-295. |
| 2. |
Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al.
A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.
N Engl J Med
1999;
340:
409-417 |
| 3. | Tang R, Chen HH, Wang YL, Changchien CR, Chen JS, Hsu KC, et al. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 2001; 234: 181-189[CrossRef][Web of Science][Medline]. |
| 4. | Parker MJ, Roberts C. Closed suction surgical wound drainage after orthopaedic surgery Cochrane Database Syst Rev 2001;4:CD001825. |
Read all Rapid Responses